Ardeparin

From WikiMD.org
Jump to navigation Jump to search

Ardeparin

Ardeparin (pronunciation: ar-de-par-in) is a type of anticoagulant medication, specifically a low molecular weight heparin (LMWH). It is used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE).

Etymology

The term "Ardeparin" is derived from the Latin words "ardeo" meaning "to burn" and "paries" meaning "wall", referring to the drug's ability to "burn" through blood clots in the "walls" of veins.

Usage

Ardeparin is used to prevent blood clots in patients who are at risk, such as those undergoing surgery or those who are bedridden due to illness. It is also used to treat existing blood clots in patients with DVT or PE.

Mechanism of Action

Ardeparin works by inhibiting the formation of blood clots. It does this by binding to the enzyme inhibitor antithrombin III (AT), which in turn inhibits the thrombin and factor Xa. Thrombin is an enzyme that promotes clotting, while factor Xa is a coagulation factor necessary for the formation of thrombin.

Side Effects

Common side effects of Ardeparin include bleeding, bruising, pain or irritation at the injection site, and anemia. Serious side effects can include severe bleeding, allergic reactions, and heparin induced thrombocytopenia (HIT).

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski